Buffered papaverine facilitates passage of intratympanic dexamethasone to the inner ear

Acta Oto-Laryngologica

Volumn 126, Issue 12, 2006, Pages 1260-1265

  Ozluoglu, Levent Naci ^a   Yilmaz, Ismail ^a   Akkuzu, Babur ^a   Haberal, Ayşegul ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Buffering; Dexamethasone; Intratympanic; Papaverine

Indexed keywords

BICARBONATE; DEXAMETHASONE; ONADRON; PAPAVERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; FEMALE; HYDROCORTISONE BLOOD LEVEL; INNER EAR; MALE; NONHUMAN; PERILYMPH; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; VENOUS BLOOD;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; EAR, INNER; FEMALE; GLUCOCORTICOIDS; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAVENOUS; MALE; PAPAVERINE; PERILYMPH; PHOSPHODIESTERASE INHIBITORS; RABBITS; TYMPANIC MEMBRANE; VASODILATOR AGENTS;

EID: 33751073177     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480500492000     Document Type: Article

References (21)

1. Hibi T, Suzuki T, Nakashima T. Perilymphatic concentration of gentamicin administered intratympanically in guinea pigs. Acta Otolaryngol 2001;121:336-41.
2. Itoh A, Sakata E. Treatment of vestibular disorders. Acta Otolaryngol Suppl 1991;481:617-23.
3. Blakley BW. Clinical forum: a review of intratympanic therapy. Am J Otol 1997;18:520-6.
4. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-9.
5. Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E, et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000;122:521-8.
6. Sakata E, Itoh A, Itoh Y. Treatment of cochlear-tinnitus with dexamethasone infusion into the tympanic cavity. Int Tinnitus J 1996;2:129-35.
7. Shea JJ, Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease. Otolaryngol Clin North Am 1996;29:353-8.
8. Doyle KJ, Bauch C, Battista R, Beatty C, Hughes GB, Mason J, et al. Intratympanic steroid treatment: a review. Otol Neurotol 2004;25:1034-9.
9. Sennaroglu L, Sennaroglu G, Gursel B, Dini FM. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease. Otolaryngol Head Neck Surg 2001;125:537-43.
10. Abou-Halawa AS, Poe DS. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Meniere's disease. Otol Neurotol 2002;23:494-502.
11. Meyerhoff WL, Cooper JC. Tinnitus. In: Paparella M, editor. Otolaryngology, 3rd edn. Philadelphia: WB Saunders; 1991. p. 1169-79.
12. Sweetman SC, ed. Martindale. The complete drug reference, 33rd edn. London: Pharmaceutical Press; 2002. p. 1067, 1648.
13. Norris CH. Drugs affecting the inner ear. A review of their clinical efficacy, mechanisms of action, toxicity, and place in therapy. Drugs 1988;36:754-72.
14. O'Neil MJ, ed. The Merck index. An encyclopedia of chemicals, drugs, and biologicals, 13th edn. Whitehouse Station, NJ: Merck; 2001. p. 518, 1257.
15. Goycoolea MV. The round window membrane under normal and pathological conditions. Acta Otolaryngol Suppl 1992;493:43-55.
16. Juhn SK, Hamaguchi Y, Goycoolea M. Review of round window membrane permeability. Acta Otolaryngol Suppl 1989;457:43-8.
17. Okuno T, Nomura Y. Permeability of the round window membrane. Arch Otorhinolaryngol 1984;240:103-6.
18. Smith BM, Meyers MG. The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol Head Neck Surg 1979;87:888-91.
19. Schachern PA, Paparella MM, Goycoolea MV, Duvall AJ 3rd, Choo YB. The permeability of round window membrane during otitis media. Arch Otolaryngol Head Neck Surg 1987;113:625-9.
20. Hamaguchi Y, Morizono T, Juhn SK. Round window membrane permeability to human serum albumin in antigen-induced otitis media. Am J Otolaryngol 1988;9:34-40.
21. Arriaga MA, Goldman S. Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope 1998;108:1682-5.